General Information
Revision date
2021-03-04
Product name
Glucagen HypoKit
1.2.2. Uses advised against
None known
Icons in SDS
Company Information
company name
Novo Nordisk Inc
GHS Information
Signal word
Not
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Solid, White powder/aqueous solution. This material is not classified as hazardous under U.S. OSHA regulations (29CFR 1910.1200) (Hazcom 2012) and Canadian WHMIS regulations (Hazardous Products Regulations) (WHMIS 2015). This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. Your needs may vary depending upon the potential for exposure in your workplace. The precautionary statements, warnings and hazards included herein may not apply in all cases, such as when the product or device is in its final form and being used to treat the approved medical condition(s) while under the care of a licensed medical professional and in accordance with the FDA-approved Prescribing Information. Refer to FDA-approved Prescribing Information for final marketed products with regard to special storage, handling and administration requirements in the clinical setting.
Hazard pictograms
None required under U.S. OSHA Hazcom 2012 and Canadian WHMIS 2015 regulations.
Signal word
Not required
Hazard statements
Not required
Precautionary statements
Not required
Other hazards which do not result in classification
GlucaGen® is an antihypoglycemic agent [increases glucose (sugar) levels in the blood] and a gastrointestinal motility inhibitor. Glucagon occurs aturally in the body. It has no activity or toxicity when ingested.No special risk if used in accordance with the instructions of the supplier.
